The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
A Novel Cell Line, MDA-kb2, That Stably Expresses an Androgen- and Glucocorticoid-Responsive Reporter for the Detection of Hormone Receptor Agonists and Antagonists
Abstract
The U.S. Environmental Protection Agency has proposed that in vitro assays for estrogen receptor (ER)- and androgen receptor (AR)-mediated actions be included in a Tier-I screening battery to detect hormonally active chemicals. Herein we describe the development of a novel stable cell line, MDA-kb2, for screening of androgen agonist and antagonists and to characterize its specificity and sensitivity to endocrine-disrupting chemicals. The breast cancer cell line, MDA-MB-453, was stably transformed with the MMTV.luciferase.neo reporter gene construct. Since both GR and AR are present in the MDA-MB-453 cells, and both receptors can act through the MMTV promoter, compounds that act through either AR or GR activate the MMTV luciferase reporter. As expected, AR agonists such as dihydrotestosterone (DHT), and GR agonists such as dexamethasone (DEX), corticosterone, and aldosterone induce luciferase expression at appropriate concentrations. DHT consistently produced 3-9-fold induction at concentrations from 0.1 to 10 nM. At 1 to 1000 nM, DEX induced luciferase activity 1.3-19.5-fold. To distinguish AR- from GR-mediated ligands, chemicals were assayed concurrently with the antiandrogen, hydroxyflutamide (OHF), which blocks AR- but not GR-mediated responses. In addition, known AR antagonists, including hydroxyflutamide, vinclozolin, vinclozolin metabolites M1 and M2, p,p'-DDE, and linuron inhibited DHT-induced luciferase gene expression at appropriate concentrations in this system. We have found that these cells are relatively easy to culture and maintain. Responsiveness was monitored over time and was stable for more than 80 passages. Some advantages of this assay are that it is relatively rapid (2 days), eliminates the need for transfection, can be conducted in a 96-well plate format, and produces consistent reproducible results. In summary, we have developed a cell line that can be used to screen chemicals, not just for AR- but for GR-mediated activities as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Persistent DDT metabolite p,p'–DDE is a potent androgen receptor antagonist
Kelce, W. R., Stone, C. R., Laws, S. C., Gray, L. E., Kemppainen, J. A., & Wilson, E. M. (1995) · Nature · doi:10.1038/375581a0 · Cited by 1,536
Chemically-induced alterations in sexual and functional development : the wildlife/human connection
Colborn, T., & Clement, C. (1992) · Medical Entomology and Zoology · Cited by 1,046
Wolf, C., Lambright, C., Mann, P., Price, M., Cooper, R. L., Ostby, J., & Gray, L. E. (1999) · Toxicology and Industrial Health · doi:10.1177/074823379901500109 · Cited by 635
Kelce, W. R., Monosson, E., Gamcsik, M. P., Laws, S. C., & Gray, L. E. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1117 · Cited by 542
Allan, G. F., Leng, X., Tsai, S. Y., Weigel, N. L., Edwards, D. P., Tsai, M. J., & O'Malley, B. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41805-4 · Cited by 355
Wong, C.-I., Kelce, W. R., Sar, M., & Wilson, E. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19998 · Cited by 337
A consensus DNA-binding site for the androgen receptor
Roche, P. J. (1992) · Molecular Endocrinology · doi:10.1210/me.6.12.2229 · Cited by 284
Parks, L. G. (2001) · Toxicological Sciences · doi:10.1093/toxsci/62.2.257 · Cited by 275
Gaido, K. W., Maness, S. C., McDonnell, D. P., Dehal, S. S., Kupfer, D., & Safe, S. H. (2000) · PubMed · Cited by 223
Lambright, C. (2000) · Toxicological Sciences · doi:10.1093/toxsci/56.2.389 · Cited by 214
Kemppainen, J. A. (1999) · Molecular Endocrinology · doi:10.1210/me.13.3.440 · Cited by 207
Environmental estrogens: health implications for humans and wildlife.
Colborn, T. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103s7135 · Cited by 204
Structural Determinants of a Glucocorticoid Receptor Recognition Element
Nordeen, S. K., Suh, B. J., Kühnel, B., & Hutchison, C. A. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-12-1866 · Cited by 198
Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
Vladusic, E. A., Hornby, A. E., Guerra-Vladusic, F. K., Lakins, J., & Lupu, R. (2000) · Oncology Reports · doi:10.3892/or.7.1.157 · Cited by 197
Steroid hormone receptors and pharmacology
Raynaud, J., Bouton, M. M., Moguilewsky, M., Ojasoo, T., Philibert, D., Beck, G., Labrie, F., & Mornon, J. (1980) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(80)90264-2 · Cited by 136
Three-Dimensional Quantitative Structure–Activity Relationships for Androgen Receptor Ligands
Waller, C. L., Juma, B. W., Gray, Jr., & Kelce, W. R. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0075 · Cited by 130
The constitution of a progesterone response element
Lieberman, B. A., Bona, B. J., Edwards, D. P., & Nordeen, S. K. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.4.8388996 · Cited by 128
Mowszowicz, I., Brown-Bieber, D., Chung, K. W., Bullock, L. P., & Bardin, C. W. (1974) · Endocrinology · doi:10.1210/endo-95-6-1589 · Cited by 121
Bentel, J. M., Birrell, S. N., Pickering, M. A., Holds, D. J., Horsfall, D. J., & Tilley, W. D. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00109-4 · Cited by 110
Kemppainen, J., & Wilson, E. M. (1996) · Urology · doi:10.1016/s0090-4295(96)00117-3 · Cited by 86
Hartig, P. C., Bobseine, K. L., Britt, B. H., Cardon, M. C., Lambright, C. R., Wilson, V. S., & Gray, L. E. (2002) · Toxicological Sciences · doi:10.1093/toxsci/66.1.82 · Cited by 84
Self-citationPoulin, R., Baker, D., Poirier, D., & Labrie, F. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf01806369 · Cited by 73
Selman, P. J., Wolfswinkel, J., & Mol, J. A. (1996) · Steroids · doi:10.1016/0039-128x(95)00216-d · Cited by 65
Hall, R. E., Tilley, W. D., McPhaul, M. J., & Sutherland, R. L. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520518 · Cited by 54
Lobaccaro, J. A., Poujol, N., Térouanne, B., Georget, V., Fabre, S., Lumbroso, S., & Sultan, C. (1999) · Endocrinology · doi:10.1210/endo.140.1.6418 · Cited by 49
Progestins can mimic, inhibit and potentiate the actions of androgens
Bardin, C. W., Brown, T. R., ISOMAA, V. V., & Jänne, O. A. (1983) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(83)90023-2 · Cited by 47
Cited by
Glyphosate-based herbicides are toxic and endocrine disruptors in human cell lines
Gasnier, C., Dumont, C., Benachour, N., Clair, E., Chagnon, M.-C., & Séralini, G.-E. (2009) · Toxicology · doi:10.1016/j.tox.2009.06.006 · Cited by 658
Hotchkiss, A. K., Rider, C. V., Blystone, C. R., Wilson, V. S., Hartig, P. C., Ankley, G. T., Foster, P. M., Gray, C. L., & Gray, L. E. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn030 · Cited by 460
Self-citationEscher, B. I., Allinson, M., Altenburger, R., Bain, P. A., Balaguer, P., Busch, W., Crago, J., Denslow, N. D., Dopp, E., Hilscherova, K., et al. (2014) · Environmental Science & Technology · doi:10.1021/es403899t · Cited by 457
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
Cochrane, D. R., Bernales, S., Jacobsen, B. M., Cittelly, D. M., Howe, E. N., D’Amato, N. C., Spoelstra, N. S., Edgerton, S. M., Jean, A., Guerrero, J., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3599 · Cited by 427
Molina-Molina, J.-M., Amaya, E., Grimaldi, M., Sáenz, J.-M., Real, M., Fernández, M. F., Balaguer, P., & Olea, N. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.015 · Cited by 374
Metadata
- Authors
- Wilson, V. S.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-03-01
- Volume
- 66
- Issue
- 1
- Pages
- 69-81
- ISSN
- 1096-0929 (ISSN-L)
- OpenAlex
- W2120798598
- Cited by
- 341
- References
- 26
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.